Medicus Pharma Ltd (NASDAQ:MDCX) price on Thursday, July 03, rose 4.97% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $3.38.
A look at the stock’s price movement, the close in the last trading session was $3.22, moving within a range at $3.3 and $3.5899. Turning to its 52-week performance, $8.94 and $1.80 were the 52-week high and 52-week low respectively. Overall, MDCX moved 33.86% over the past month.
Medicus Pharma Ltd’s market cap currently stands at around $53.86 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-11.
MDCX’s current price about 21.32% and -16.04% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 52.26, while 7-day volatility ratio is 11.70% and 11.22% in the 30-day chart. Further, Medicus Pharma Ltd (MDCX) has a beta value of 0.
If we refocus on Medicus Pharma Ltd (NASDAQ:MDCX), historical trading data shows that trading volumes averaged 0.31 over the past 10 days and 250.70K over the past 3 months. The company’s latest data on shares outstanding shows there are 13.42 million shares.
The 80.22% of Medicus Pharma Ltd’s shares are in the hands of company insiders while institutional holders own 25.85% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.11 million on 2025-06-13, giving us a short ratio of 0.25. The data shows that as of 2025-06-13 short interest in Medicus Pharma Ltd (MDCX) stood at 117.0 of shares outstanding, with shares short falling to 0.27 million registered in 2025-05-15. It is this reason that could see investor optimism for the MDCX stock continues to rise going into the next quarter.
